FDG PET/CT as a Prognostic Biomarker in the Era of Molecular-Targeting Therapies: Max SUVmax Predicts Survival of Patients With Advanced Renal Cell Carcinoma

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2097-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

18f-FDG PET/CT Parameters as Imaging Biomarker Is Useful in Oral Squamous Cell Carcinoma Patients

Journal of Japanese Society of Oral Oncology
2017English

The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations

Frontiers in Oncology
Cancer ResearchOncology
2016English

Meta-Analysis of the Diagnostic Performance of [18f]fdg-Pet and PET/CT in Renal Cell Carcinoma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2012English

Role of F18-FDG-Pet/Ct in Restaging Patients Affected by Renal Carcinoma

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2013English

Palatine Tonsil SUVmax on FDG PET-CT as a Discriminator Between Benign and Malignant Tonsils in Patients With and Without Head and Neck Squamous Cell Carcinoma of Unknown Primary

Clinical Radiology
MedicineNuclear MedicineRadiologyImaging
2019English

Prognostic Value of SUVmax on 18f-Fluorodeoxyglucose PET/CT Scan in Patients With Malignant Pleural Mesothelioma

PLoS ONE
Multidisciplinary
2020English

Prognostic Value of SUVmax and Metabolic Tumor Volume on 18f-FDG PET/CT in Early Stage Non-Small Cell Lung Cancer Patients Without LN Metastasis

Bio-Medical Materials and Engineering
MedicineBiomaterialsBiomedical Engineering
2014English

Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18f-FDG PET/CT in Patients With Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy